Skip to main content

Published locations for NHL: As a second-line treatment in phase 3 trial, tisa-cel disappoints

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. NHL: As a second-line treatment in phase 3 trial, tisa-cel disappoints

User login

  • Reset your password
  • /content/nhl-second-line-treatment-phase-3-trial-tisa-cel-disappoints
  • /fedprac/article/249928/aggressive-lymphomas/nhl-second-line-treatment-phase-3-trial-tisa-cel
  • /hematologynews/article/249928/aggressive-lymphomas/nhl-second-line-treatment-phase-3-trial-tisa-cel
  • /fedprac/avaho/article/249928/aggressive-lymphomas/nhl-second-line-treatment-phase-3-trial-tisa-cel
  • /hematology-oncology/article/249928/aggressive-lymphomas/nhl-second-line-treatment-phase-3-trial-tisa
  • /breast-cancer-icymi/article/249928/aggressive-lymphomas/nhl-second-line-treatment-phase-3-trial-tisa
  • /b-cell-lymphoma-icymi/article/249928/aggressive-lymphomas/nhl-second-line-treatment-phase-3-trial